Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes — Stella

Home/PreDiabetes/Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

View on ClinicalTrials.gov

Recruiting

Back to PreDiabetes trials

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

UTHealth Clinical Research Unit (CRU) at UT Brownsville, Brownsville, Texas

Key details

Phase

Post-approval study

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

Vanderbilt University Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~300 participants

Started

November 2021

Primary completion

October 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.